Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, American Healthcare REIT Inc’s stock clocked out at $45.3, up 1.66% from its previous closing price of $44.56. In other words, the price has increased by $1.66 from its previous closing price. On the day, 3.07 million shares were traded. AHR stock price reached its highest trading level at $45.46 during the session, while it also had its lowest trading level at $44.41.
Ratios:
To gain a deeper understanding of AHR’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 45.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.44. For the most recent quarter (mrq), Quick Ratio is recorded 1.52 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, UBS on September 19, 2025, initiated with a Buy rating and assigned the stock a target price of $51.
On July 18, 2025, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $41.
On June 30, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $42.Scotiabank initiated its Sector Outperform rating on June 30, 2025, with a $42 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 03 ’25 when Foster Mark E. sold 3,850 shares for $41.89 per share. The transaction valued at 161,271 led to the insider holds 59,100 shares of the business.
Foster Mark E. bought 3,850 shares of AHR for $161,271 on Sep 03 ’25. On Jun 30 ’25, another insider, Oh Stefan K.L., who serves as the Chief Investment Officer of the company, sold 3,860 shares for $36.10 each. As a result, the insider received 139,346 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHR now has a Market Capitalization of 7636456448 and an Enterprise Value of 9261605888. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.59 while its Price-to-Book (P/B) ratio in mrq is 3.08. Its current Enterprise Value per Revenue stands at 4.324 whereas that against EBITDA is 25.62.
Stock Price History:
The Beta on a monthly basis for AHR is 0.95, which has changed by 0.7309897 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, AHR has reached a high of $45.00, while it has fallen to a 52-week low of $24.21. The 50-Day Moving Average of the stock is 6.73%, while the 200-Day Moving Average is calculated to be 28.06%.
Shares Statistics:
It appears that AHR traded 1.44M shares on average per day over the past three months and 1453050 shares per day over the past ten days. A total of 168.57M shares are outstanding, with a floating share count of 166.93M. Insiders hold about 0.98% of the company’s shares, while institutions hold 89.57% stake in the company. Shares short for AHR as of 1760486400 were 7222033 with a Short Ratio of 5.00, compared to 1757894400 on 5745018. Therefore, it implies a Short% of Shares Outstanding of 7222033 and a Short% of Float of 4.32.
Earnings Estimates
A comprehensive evaluation of American Healthcare REIT Inc (AHR) is underway, with the input of 3.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.17, with high estimates of $0.19 and low estimates of $0.15.
Analysts are recommending an EPS of between $0.37 and $0.31 for the fiscal current year, implying an average EPS of $0.34. EPS for the following year is $0.78, with 3.0 analysts recommending between $0.81 and $0.76.
Revenue Estimates
In. The current quarter, 6 analysts expect revenue to total $552.14M. It ranges from a high estimate of $565.26M to a low estimate of $547.4M. As of. The current estimate, American Healthcare REIT Inc’s year-ago sales were $523.81MFor the next quarter, 6 analysts are estimating revenue of $563.61M. There is a high estimate of $592.53M for the next quarter, whereas the lowest estimate is $552.6M.
A total of 6 analysts have provided revenue estimates for AHR’s current fiscal year. The highest revenue estimate was $2.24B, while the lowest revenue estimate was $2.18B, resulting in an average revenue estimate of $2.2B. In the same quarter a year ago, actual revenue was $2.07BBased on 6 analysts’ estimates, the company’s revenue will be $2.35B in the next fiscal year. The high estimate is $2.52B and the low estimate is $2.3B.
